Effect of Lavender Inhalation on Dysmenorrhea

Study Overview
=================
Brief Summary
-----------------
This study was planned to determine the effect of lavender inhalation on primary dysmenorrhea and its symptoms.

Detailed Description
-----------------
The research is a randomized controlled trial and an experimental research design will be used. The research will be carried out with two groups as experimental (lavender) and control (placebo) groups.

Official Title
-----------------
Effect of Lavender Inhalation on Primary Dysmenorrhea

Conditions
-----------------
Dysmenorrhea

Intervention / Treatment
-----------------
* Other: Lavender oil inhalation
* Other: Placebo


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Having primary dysmenorrhea (degrees II and III), Single, Who have never been pregnant before, Having a regular menstrual cycle Without any genital organ disorder (such as fibroids, fibroadenoma, endometriosis, metrorrhagia, ovarian cyst, pelvic inflammatory disease, chronic pelvic pain, other pelvic pathologies) Not using contraceptive method, Having a normal sense of smell People who can smell odors and are not allergic to odors will be included in the study. Exclusion Criteria: Married, Having a disease that causes dysmenorrhea, Regularly using a pharmacological and non-pharmacological method to relieve Dysmenorrhea pain during the study, Having a previous or unconcluded pregnancy, Having a chronic disease (diabetes, endometriosis, uterine congenital anomalies, epilepsy, etc.), Using drugs that affect the menstrual cycle or dysmenorrhea, Persons who fill in the data collection form incompletely or not at all will not be included in the study.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 30 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Experimental group<br>Lavender inhalation will be administered to this group. | Other: Lavender oil inhalation<br>* Lavender inhalation will be administered to this group. Participants will be asked to drop three drops of lavender oil solution on a small piece of cotton on the 1st, 2nd, and 3rd days of their first menstrual bleeding after enrollment in the study, hold it 7-10 cm from their noses, and sniff for 5 minutes. Participants will be asked to apply this application immediately after the onset of dysmenorrhea pain on the first day of their menstruation and to continue regularly every 8 hours for the first three days of menstrual bleeding. Participants will be asked to apply this application in the same way in two consecutive menstrual cycles and the participants will be followed in this process.<br>|
| Placebo Comparator: Placebo group<br>Olive oil will be administered to the placebo group. | Other: Placebo<br>* Olive oil will be administered to the placebo group. The application will be similar to the experimental group.<br>* Other names: Olive oil;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Dysmenorrhea Symptom Assessment Form | Form consists of questions about dysmenorrhea symptoms in the participants.As the score obtained from the form increases, the severity of the symptoms increases. | to assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles. | 
| Numerical Pain Scale | It will be applied to evaluate the level of dysmenorrhea pain. Participants will be asked to rate their pain level from 0 to 10. As the score increases, the level of pain increases | to assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles. |